USFDA completes Lupin’s Goa facility inspection without any observations

22 Jul 2017 Evaluate

US Food and Drug Administration (USFDA) has successfully completed Prior Approval Inspection (PAI) at Lupin’s Goa manufacturing facility without any observations. The inspection which started on July 17 concluded on July 21, 2017.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2119.50 -31.55 (-1.47%)
01-Feb-2026 13:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.85
Dr. Reddys Lab 1223.15
Cipla 1315.45
Zydus Lifesciences 883.80
Lupin 2119.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×